IRIDEX CORPORATION - COMMON STOCK

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

12 يناير 2026 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management

11 ديسمبر 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

08 ديسمبر 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

05 ديسمبر 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex Reports Third Quarter 2025 Financial Results

11 نوفمبر 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

28 أكتوبر 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

09 سبتمبر 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex Reports Second Quarter 2025 Financial Results

12 أغسطس 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

29 يوليو 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

24 يونيو 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex Reports First Quarter 2025 Financial Results

13 مايو 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

30 أبريل 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

14 أبريل 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex to Host Strategic Vision Call on April 16, 2025

09 أبريل 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

27 مارس 2025 16:05:00 بحسب Nasdaq GlobeNewswire

Iridex Announces Strategic Investment in the Company

19 مارس 2025 09:15:17 بحسب Nasdaq GlobeNewswire

Iridex Comments on Recent Stock Price Volatility

14 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

13 مارس 2025 17:00:00 بحسب Nasdaq GlobeNewswire

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024

14 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

18 ديسمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire